| 281 |
Fluvoxamine, a Selective Serotonin Reuptake Inhibitor Versus Other Antidepressants in the Treatment of Depressed Patients: A Meta-Analysis of Efficacy, Acceptability and Safety |
2012 |
| 282 |
Fluvoxamine, a selective serotonin reuptake inhibitor versus other antidepressants in the treatment of depressed patients: a meta-analysis of efficacy, acceptability and safety. |
2012 |
| 283 |
Fluvoxamine, a selective serotonin reuptake inhibitor versus other antidepressants in the treatment of depressed patients: a meta-analysis of efficacy, acceptability and safety. |
2012 |
| 284 |
Fluvoxamine, a selective serotonin reuptake inhibitor versus other antidepressants in the treatment of depressed patients: a meta-analysis of efficacy, acceptability and safety. |
2012 |
| 285 |
Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats. |
2012 |
| 286 |
Involvement of GABA-ergic transmission in the anticonvulsant effect of Ginkgo biloba against kainic acid-induced seizures in mice. |
2012 |
| 287 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 288 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 289 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |
| 290 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the
convulsant activity of ciprofloxacin in mice |
2012 |